Bill Seeks to Create a National Cannabis Study Agenda


Representatives Donna Shalala and Matt Gaetz have introduced a bipartisan bill that seeks to reclassify cannabis at a federal level in order to enhance investigation efforts.

The Expanding Cannabis Study and Facts Act seeks to move marijuana from Schedule I to Schedule III of the Controlled Substances Act.

Shalala and Gaetz think that its existing classification prevents scientists from correctly examining its rewards and effects. Moving it down to Schedule III would make it less difficult for researchers to study cannabis and lessen the conflict among the federal government and the 33 states that have legalized health-related cannabis use.

“By rescheduling cannabis and directing our national investigation infrastructure to study and gather information on how it impacts overall health outcomes, we are not only bringing federal cannabis policy into the 21st century, but we’re also guaranteeing that we do so safely,” mentioned Shalala, a Democrat.

She previously served as Wellness and Human Solutions secretary in the course of the Clinton administration. At the time, she was a prominent critic of cannabis liberalization, but she has because changed her tune and mentioned that decriminalizing marijuana should really be thought of a moral crucial.

Gaetz is a Republican and he has regularly efforts to reclassify cannabis in the previous. He desires to strengthen, expedite and streamline cannabis investigation in order to create a superior scientific understanding of its brief and extended-term rewards and effects of cannabis on human overall health.

The Expanding Cannabis Study and Facts Act is identical companion legislation to a bill filed by Sen. Dick Durbin in July.

It would create a national cannabis investigation agenda, instruct the U.S. Division of Wellness and Human Solutions to gather information on the overall health impacts of cannabis and establish a National Institutes of Wellness “Centers of Excellence” investigation designation, along with reclassifying cannabis as a Schedule III controlled substance.

It follows news of the DEA unveiling plans to raise the quantity of marijuana legally made for investigation purposes in the U.S. by 30% in 2020.


Latest posts